Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3)

Andreas M. Kaufmann, John D. Nieland, Ingrid Jochmus, Siegfried Baur, Klaus Friese, Joseph Gabelsberger, Friederike Gieseking, Lutz Gissmann, Birgit Glasschröder, Thomas Grubert, Peter Hillemanns, Reinhard Höpfl, Hans Ikenberg, Jörg Schwarz, Matthias Karrasch, Anette Knoll, Volkmar Küppers, Martin Lechmann, Ralph J. Lelle, Harald MeissnerRainer T. Müller, Michael Pawlita, Karl Ulrich Petry, Henryk Pilch, Elke Walek, Achim Schneider*

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

105 Citations (Scopus)
Original languageEnglish
JournalInternational Journal of Cancer
Volume121
Issue number12
Pages (from-to)2794-2800
Number of pages7
ISSN0020-7136
DOIs
Publication statusPublished - 15 Nov 2007
Externally publishedYes

Keywords

  • Antibody
  • Cervical cancer
  • Clinical trial
  • Immunization
  • T cell

Fingerprint

Dive into the research topics of 'Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3)'. Together they form a unique fingerprint.

Cite this